{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:37:57Z","timestamp":1793738277712,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11011-023-01304-5","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T08:02:39Z","timestamp":1697616159000},"page":"2721-2733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Unlocking therapeutic potential of trigonelline through molecular docking as a promising approach for treating diverse neurological disorders"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-0204","authenticated-orcid":false,"given":"Syeda Rehana","family":"Zia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-6609","authenticated-orcid":false,"given":"Muhammad","family":"Wasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2856-4022","authenticated-orcid":false,"given":"Saara","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"1304_CR1","doi-asserted-by":"publisher","first-page":"100880","DOI":"10.1016\/j.imu.2022.100880","volume":"29","author":"TI Adelusi","year":"2022","unstructured":"Adelusi TI, Oyedele A-QK, Boyenle ID et al (2022) Molecular modeling in drug discovery. Inform Med Unlocked 29:100880. https:\/\/doi.org\/10.1016\/j.imu.2022.100880","journal-title":"Inform Med Unlocked"},{"key":"1304_CR2","doi-asserted-by":"publisher","first-page":"e10774","DOI":"10.1016\/j.heliyon.2022.e10774","volume":"8","author":"S Ahmad","year":"2022","unstructured":"Ahmad S, Azhar A, Tikmani P, Rafique H, Khan A, Mesiya H, Saeed H (2022a) A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients. Heliyon 8:e10774. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10774","journal-title":"Heliyon"},{"key":"1304_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/2211556010666210906153253","volume":"11","author":"S Ahmad","year":"2022","unstructured":"Ahmad S, Khan A, Tabassum S et al (2022b) Co-administration of saffron and chamomile give additive effects of antidiabetic and antioxidant activity with in vivo augmentation of brain BDNF, acetylcholine levels and cognitive functions in Streptozotocininduced diabetic rats. Curr Psychopharmacol 11:56\u201369. https:\/\/doi.org\/10.2174\/2211556010666210906153253","journal-title":"Curr Psychopharmacol"},{"key":"1304_CR4","doi-asserted-by":"publisher","first-page":"e0276236","DOI":"10.1371\/journal.pone.0276236","volume":"17","author":"S Ahmad","year":"2022","unstructured":"Ahmad S, Rafiq H, Khan A et al (2022c) Ameliorative effects of half-dose saffron and chamomile combination on psycho-endocrinological changes in a diabetic murine model. PLoS One 17:e0276236. https:\/\/doi.org\/10.1371\/journal.pone.0276236","journal-title":"PLoS One"},{"key":"1304_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11011-022-01063-9","volume":"38","author":"S Ahmad","year":"2023","unstructured":"Ahmad S, Ahmed SB, Khan A et al (2023) Natural remedies for Alzheimer's disease: a systematic review of randomized controlled trials. Metab Brain Dis 38:17\u201344. https:\/\/doi.org\/10.1007\/s11011-022-01063-9","journal-title":"Metab Brain Dis"},{"key":"1304_CR6","doi-asserted-by":"publisher","unstructured":"Amin F, Ibrahim MAA, Rizwan-Ul-Hasan S et al (2022) Interactions of Apigenin and Safranal with the 5HT1A and 5HT2A receptors and behavioral effects in depression and anxiety: a molecular docking, lipid-mediated molecular dynamics, and in vivo analysis. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27248658","DOI":"10.3390\/molecules27248658"},{"key":"1304_CR7","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/onc.2012.493","volume":"32","author":"A Arlt","year":"2013","unstructured":"Arlt A, Sebens S, Krebs S et al (2013) Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32:4825\u20134835. https:\/\/doi.org\/10.1038\/onc.2012.493","journal-title":"Oncogene"},{"key":"1304_CR8","doi-asserted-by":"publisher","unstructured":"Attique SA, Hassan M, Usman M et al (2019) A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension. Int J Environ Res Public Health 16. https:\/\/doi.org\/10.3390\/ijerph16060923","DOI":"10.3390\/ijerph16060923"},{"key":"1304_CR9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1107\/s0907444902003451","volume":"58","author":"HM Berman","year":"2002","unstructured":"Berman HM, Battistuz T, Bhat TN et al (2002) The protein data bank. Acta Crystallogr D Biol Crystallogr 58:899\u2013907. https:\/\/doi.org\/10.1107\/s0907444902003451","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1304_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.phymed.2017.09.023","volume":"36","author":"R Casta\u00f1eda","year":"2017","unstructured":"Casta\u00f1eda R, Rodriguez I, Nam YH, Hong BN, Kang TH (2017) Trigonelline promotes auditory function through nerve growth factor signaling on diabetic animal models. Phytomedicine 36:128\u2013136. https:\/\/doi.org\/10.1016\/j.phymed.2017.09.023","journal-title":"Phytomedicine"},{"key":"1304_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pharep.2017.09.006","volume":"70","author":"AA Chowdhury","year":"2018","unstructured":"Chowdhury AA, Gawali NB, Bulani VD, Kothavade PS, Mestry SN, Deshpande PS, Juvekar AR (2018a) In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d-galactose induced cognitive impairment. Pharmacol Rep 70:372\u2013377. https:\/\/doi.org\/10.1016\/j.pharep.2017.09.006","journal-title":"Pharmacol Rep"},{"key":"1304_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11011-017-0147-5","volume":"33","author":"AA Chowdhury","year":"2018","unstructured":"Chowdhury AA, Gawali NB, Munshi R, Juvekar AR (2018b) Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice. Metab Brain Dis 33:681\u2013691. https:\/\/doi.org\/10.1007\/s11011-017-0147-5","journal-title":"Metab Brain Dis"},{"key":"1304_CR13","doi-asserted-by":"publisher","unstructured":"de Mol NJ, Fischer MJ (2008) Kinetic and thermodynamic analysis of ligand-receptor interactions: SPR applications in drug development. Handbook of surface plasmon resonance, pp 123\u2013172. https:\/\/doi.org\/10.1039\/9780854042678-00123","DOI":"10.1039\/9780854042678-00123"},{"key":"1304_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/aabc.s105289","volume":"9","author":"J de Ruyck","year":"2016","unstructured":"de Ruyck J, Brysbaert G, Blossey R, Lensink MF (2016) Molecular docking as a popular tool in drug design, an in silico travel. Adv Appl Bioinform Chem 9:1\u201311. https:\/\/doi.org\/10.2147\/aabc.s105289","journal-title":"Adv Appl Bioinform Chem"},{"key":"1304_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11011-018-0338-8","volume":"34","author":"J Fahanik-Babaei","year":"2019","unstructured":"Fahanik-Babaei J, Baluchnejadmojarad T, Nikbakht F, Roghani M (2019) Trigonelline protects hippocampus against intracerebral A\u03b2(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms. Metab Brain Dis 34:191\u2013201. https:\/\/doi.org\/10.1007\/s11011-018-0338-8","journal-title":"Metab Brain Dis"},{"key":"1304_CR16","doi-asserted-by":"publisher","first-page":"W337","DOI":"10.1093\/nar\/gkx333","volume":"45","author":"R Fahrrolfes","year":"2017","unstructured":"Fahrrolfes R, Bietz S, Flachsenberg F et al (2017) ProteinsPlus: a web portal for structure analysis of macromolecules. Nucleic Acids Res 45:W337\u2013W343. https:\/\/doi.org\/10.1093\/nar\/gkx333","journal-title":"Nucleic Acids Res"},{"key":"1304_CR17","doi-asserted-by":"publisher","first-page":"16424","DOI":"10.1038\/s41598-020-73514-1","volume":"10","author":"MM Farid","year":"2020","unstructured":"Farid MM, Yang X, Kuboyama T, Tohda C (2020) Trigonelline recovers memory function in Alzheimer's disease model mice: evidence of brain penetration and target molecule. Sci Rep 10:16424. https:\/\/doi.org\/10.1038\/s41598-020-73514-1","journal-title":"Sci Rep"},{"key":"1304_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mnfr.201300936","volume":"58","author":"J Folwarczna","year":"2014","unstructured":"Folwarczna J, Zych M, Nowinska B, Pytlik M, Janas A (2014) Unfavorable effect of trigonelline, an alkaloid present in coffee and fenugreek, on bone mechanical properties in estrogen-deficient rats. Mol Nutr Food Res 58:1457\u20131464. https:\/\/doi.org\/10.1002\/mnfr.201300936","journal-title":"Mol Nutr Food Res"},{"key":"1304_CR19","doi-asserted-by":"publisher","first-page":"105038","DOI":"10.1016\/j.tiv.2020.105038","volume":"70","author":"C Fouzder","year":"2021","unstructured":"Fouzder C, Mukhuty A, Mukherjee S, Malick C, Kundu R (2021) Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of cisplatin and etoposide in NSCLC cells. Toxicol in Vitro 70:105038. https:\/\/doi.org\/10.1016\/j.tiv.2020.105038","journal-title":"Toxicol in Vitro"},{"key":"1304_CR20","doi-asserted-by":"publisher","unstructured":"Iqbal A (2023) Molecular docking in the study of ligand-protein recognition: an overview. In: Erman Salih I (ed) Molecular Docking. IntechOpen, Rijeka, p Ch. 4. https:\/\/doi.org\/10.5772\/intechopen.106583","DOI":"10.5772\/intechopen.106583"},{"key":"1304_CR21","unstructured":"Javad F-B, Tourandokht B, Farnaz N, Mehrdad R (2019) Trigonelline ameliorates learning and memory and synaptic plasticity impairment in Intrahippocampal amyloid Beta (1-40) rat model of Alzheimer\u2019s disease. Acta Medica Iranica 56(10).\u00a0https:\/\/acta.tums.ac.ir\/index.php\/acta\/article\/view\/6874"},{"key":"1304_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.intimp.2018.06.019","volume":"61","author":"M Khalili","year":"2018","unstructured":"Khalili M, Alavi M, Esmaeil-Jamaat E, Baluchnejadmojarad T, Roghani M (2018) Trigonelline mitigates lipopolysaccharide-induced learning and memory impairment in the rat due to its anti-oxidative and anti-inflammatory effect. Int Immunopharmacol 61:355\u2013362. https:\/\/doi.org\/10.1016\/j.intimp.2018.06.019","journal-title":"Int Immunopharmacol"},{"key":"1304_CR23","doi-asserted-by":"crossref","unstructured":"Khan RA, Assad T, Rajput MA (2017) Anticonvulsant effects of Trigonella foenum-graecum L. in strychnine induced epilepsy model.\u00a0J Nutrition Health Food Sci\u00a05(7):1\u20136","DOI":"10.15226\/jnhfs.2017.001115"},{"key":"1304_CR24","doi-asserted-by":"publisher","unstructured":"Konstantinidis N, Franke H, Schwarz S, Lachenmeier DW (2023) Risk assessment of Trigonelline in coffee and coffee by-products. Molecules 28. https:\/\/doi.org\/10.3390\/molecules28083460","DOI":"10.3390\/molecules28083460"},{"key":"1304_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biochi.2022.10.009","volume":"206","author":"Y Liang","year":"2023","unstructured":"Liang Y, Dai X, Cao Y et al (2023) The neuroprotective and antidiabetic effects of trigonelline: a review of signaling pathways and molecular mechanisms. Biochimie 206:93\u2013104. https:\/\/doi.org\/10.1016\/j.biochi.2022.10.009","journal-title":"Biochimie"},{"key":"1304_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000503728","volume":"105","author":"Z Lorigooini","year":"2020","unstructured":"Lorigooini Z, Sadeghi Dehsahraei K, Bijad E, Habibian Dehkordi S, Amini-Khoei H (2020) Trigonelline through the attenuation of oxidative stress exerts antidepressant- and anxiolytic-like effects in a mouse model of maternal separation stress. Pharmacology 105:289\u2013299. https:\/\/doi.org\/10.1159\/000503728","journal-title":"Pharmacology"},{"key":"1304_CR27","doi-asserted-by":"publisher","unstructured":"Luo W, Deng J, He J et al (2023) Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi-target pharmacology of fenugreek against diabetes. J Cell Mol Med. https:\/\/doi.org\/10.1111\/jcmm.17787","DOI":"10.1111\/jcmm.17787"},{"key":"1304_CR28","doi-asserted-by":"publisher","unstructured":"Martinez JC, Murciano-Calles J, Cobos ES, Iglesias-Bexiga M, Luque I, Ruiz-Sanz J (2013) Isothermal titration calorimetry: thermodynamic analysis of the binding thermograms of molecular recognition events by using equilibrium models, vol 4.\u00a0InTech. https:\/\/doi.org\/10.5772\/53311","DOI":"10.5772\/53311"},{"key":"1304_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2011","unstructured":"Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146\u2013157. https:\/\/doi.org\/10.2174\/157340911795677602","journal-title":"Curr Comput Aided Drug Des"},{"key":"1304_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11062-016-9586-6","volume":"48","author":"M Mirzaie","year":"2016","unstructured":"Mirzaie M, Khalili M, Kiasalari Z, Roghani M (2016) Neuroprotective and Antiapoptotic potential of Trigonelline in a striatal 6-Hydroxydopamine rat model of Parkinson\u2019s disease. Neurophysiology 48:176\u2013183. https:\/\/doi.org\/10.1007\/s11062-016-9586-6","journal-title":"Neurophysiology"},{"key":"1304_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molimm.2019.12.020","volume":"118","author":"AD Nugrahini","year":"2020","unstructured":"Nugrahini AD, Ishida M, Nakagawa T, Nishi K, Sugahara T (2020) Trigonelline: an alkaloid with anti-degranulation properties. Mol Immunol 118:201\u2013209","journal-title":"Mol Immunol"},{"key":"1304_CR32","doi-asserted-by":"publisher","first-page":"e0284210","DOI":"10.1371\/journal.pone.0284210","volume":"18","author":"OS Okoh","year":"2023","unstructured":"Okoh OS, Yakubu A, Adegboyega AE et al (2023) Identification of some bioactive compounds from Trignonella foenumgraecum as possible inhibitors of PPAR\u03d2 for diabetes treatment through molecular docking studies, pharmacophore modelling and ADMET profiling: an in-silico study. PLoS One 18:e0284210. https:\/\/doi.org\/10.1371\/journal.pone.0284210","journal-title":"PLoS One"},{"key":"1304_CR33","doi-asserted-by":"publisher","unstructured":"Pinzi L, Rastelli G (2019) Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20184331","DOI":"10.3390\/ijms20184331"},{"key":"1304_CR34","doi-asserted-by":"publisher","unstructured":"Prieto-Mart\u00ednez FD, Arciniega M, Medina-Franco JL (2018) Molecular docking: current advances and challenges. TIP Revista especializada en ciencias qu\u00edmico-biol\u00f3gicas, p 21. https:\/\/doi.org\/10.22201\/fesz.23958723e.2018.0.143","DOI":"10.22201\/fesz.23958723e.2018.0.143"},{"key":"1304_CR35","doi-asserted-by":"publisher","first-page":"108946","DOI":"10.1016\/j.cbi.2020.108946","volume":"317","author":"Z Qiu","year":"2020","unstructured":"Qiu Z, Wang K, Jiang C et al (2020) Trigonelline protects hippocampal neurons from oxygen-glucose deprivation-induced injury through activating the PI3K\/Akt pathway. Chem Biol Interact 317:108946. https:\/\/doi.org\/10.1016\/j.cbi.2020.108946","journal-title":"Chem Biol Interact"},{"key":"1304_CR36","doi-asserted-by":"publisher","unstructured":"Roshana Devi V, Sharmila C, Subramanian S (2018) Molecular docking studies involving the inhibitory effect of Gymnemic acid, Trigonelline and Ferulic acid, the phytochemicals with antidiabetic properties, on glycogen synthase kinase 3 (\u03b1 and \u03b2).\u00a0J App Pharm Sci 8(4):150\u2013160. https:\/\/doi.org\/10.7324\/JAPS.2018.8422","DOI":"10.7324\/JAPS.2018.8422"},{"key":"1304_CR37","doi-asserted-by":"publisher","unstructured":"Ruggiero M, Calvello R, Porro C, Messina G, Cianciulli A, Panaro MA (2022) Neurodegenerative diseases: can caffeine be a powerful ally to weaken neuroinflammation? Int J Mol Sci 23(21):12958. https:\/\/doi.org\/10.3390\/ijms232112958","DOI":"10.3390\/ijms232112958"},{"key":"1304_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2023.03.022","volume":"203","author":"Q Shen","year":"2023","unstructured":"Shen Q, Fang J, Guo H et al (2023) Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE\/TFAM signaling in diabetic kidney disease. Free Radic Biol Med 203:45\u201357. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.022","journal-title":"Free Radic Biol Med"},{"key":"1304_CR39","doi-asserted-by":"publisher","unstructured":"Socala K, Szopa A, Serefko A, Poleszak E, Wlaz P (2020) Neuroprotective effects of coffee bioactive compounds: a review. Int J Mol Sci 22(1):107. https:\/\/doi.org\/10.3390\/ijms22010107","DOI":"10.3390\/ijms22010107"},{"key":"1304_CR40","doi-asserted-by":"publisher","first-page":"9577874","DOI":"10.1155\/2021\/9577874","volume":"2021","author":"J Sun","year":"2021","unstructured":"Sun J, Li JY, Zhang LQ et al (2021) Nrf2 activation attenuates chronic constriction injury-induced neuropathic pain via induction of PGC-1alpha-mediated mitochondrial biogenesis in the spinal cord. Oxidative Med Cell Longev 2021:9577874. https:\/\/doi.org\/10.1155\/2021\/9577874","journal-title":"Oxidative Med Cell Longev"},{"key":"1304_CR41","doi-asserted-by":"publisher","unstructured":"Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP (2019) Key topics in molecular docking for drug design. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20184574","DOI":"10.3390\/ijms20184574"},{"key":"1304_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/1028415X.2017.1327200","volume":"21","author":"S Zameer","year":"2018","unstructured":"Zameer S, Najmi AK, Vohora D, Akhtar M (2018) A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential. Nutr Neurosci 21:539\u2013545. https:\/\/doi.org\/10.1080\/1028415X.2017.1327200","journal-title":"Nutr Neurosci"},{"key":"1304_CR43","doi-asserted-by":"publisher","first-page":"687970","DOI":"10.3389\/fphar.2021.687970","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang Y, Chen S et al (2021) Trigonelline, an alkaloid from Leonurus japonicus Houtt., suppresses mast cell activation and OVA-induced allergic asthma. Front Pharmacol 12:687970. https:\/\/doi.org\/10.3389\/fphar.2021.687970","journal-title":"Front Pharmacol"},{"key":"1304_CR44","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.7150\/ijbs.82401","volume":"19","author":"J Zhang","year":"2023","unstructured":"Zhang J, Xu H-X, Zhu J-Q, Dou Y-X, Xian Y-F, Lin Z-X (2023) Natural Nrf2 inhibitors: a review of their potential for Cancer treatment. Int J Biol Sci 19:3029\u20133041. https:\/\/doi.org\/10.7150\/ijbs.82401","journal-title":"Int J Biol Sci"},{"key":"1304_CR45","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.2174\/092986712801323171","volume":"19","author":"J Zhou","year":"2012","unstructured":"Zhou J, Chan L, Zhou S (2012) Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem 19:3523\u20133531. https:\/\/doi.org\/10.2174\/092986712801323171","journal-title":"Curr Med Chem"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01304-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-023-01304-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01304-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T08:17:12Z","timestamp":1700554632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-023-01304-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1007\/s11011-023-01304-5","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nothing to declare. The research was conducted in the absence of any financial and commercial relationship.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}